tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Catalyst Pharma’s Strong Growth Prospects and Strategic Initiatives Drive Buy Rating
PremiumRatingsCatalyst Pharma’s Strong Growth Prospects and Strategic Initiatives Drive Buy Rating
2M ago
Catalyst Pharmaceuticals Reports Record Q1 2025 Results
Premium
Company Announcements
Catalyst Pharmaceuticals Reports Record Q1 2025 Results
2M ago
Catalyst Pharmaceuticals Reports Robust Growth in Earnings Call
Premium
Company Announcements
Catalyst Pharmaceuticals Reports Robust Growth in Earnings Call
2M ago
Catalyst Pharmaceuticals price target raised to $34 from $33 at BofA
PremiumThe FlyCatalyst Pharmaceuticals price target raised to $34 from $33 at BofA
3M ago
Catalyst Pharmaceuticals announces Health Canada’s acceptance of AGAMREE NDS
Premium
The Fly
Catalyst Pharmaceuticals announces Health Canada’s acceptance of AGAMREE NDS
3M ago
Catalyst Pharmaceuticals submits NDS to Health Canada for Agamree
Premium
The Fly
Catalyst Pharmaceuticals submits NDS to Health Canada for Agamree
3M ago
Catalyst Pharmaceuticals price target raised to $40 from $33 at Stephens
PremiumThe FlyCatalyst Pharmaceuticals price target raised to $40 from $33 at Stephens
5M ago
Catalyst Pharmaceuticals Reports Record 2024 Financial Results
Premium
Company Announcements
Catalyst Pharmaceuticals Reports Record 2024 Financial Results
5M ago
Catalyst Pharmaceuticals Reports Strong Growth Amid Challenges
Premium
Company Announcements
Catalyst Pharmaceuticals Reports Strong Growth Amid Challenges
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100